Open access · US-GOV via ClinicalTrials.gov Clinical trial

The Role of Qmax/eGFR Ratio in Assessing Symptom Severity and QoL in Men Over 40 With LUTS

Authors not listed

Marmara University · 2025

Dysbiosis Human Randomized controlled trial

Abstract

This study will look at how well a measure called the Qmax/eGFR ratio is related to the severity of urination problems in men over the age of 40. Qmax is a test that shows how fast a person can urinate, and eGFR is a number that reflects kidney function. Men who have urinary symptoms will be asked to do a urine flow test, a blood test, and fill out a questionnaire about their symptoms and quality of life. We will study if there is a link between the Qmax/eGFR ratio and how severe their symptoms are. The results may help doctors better understand how kidney and urinary function are related in men with these problems.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-20 MST

Cite this

APA

Anonymous. (2025). The Role of Qmax/eGFR Ratio in Assessing Symptom Severity and QoL in Men Over 40 With LUTS. <em>Marmara University</em>. https://clinicaltrials.gov/study/NCT07055425

Vancouver

Anonymous. The Role of Qmax/eGFR Ratio in Assessing Symptom Severity and QoL in Men Over 40 With LUTS. Marmara University. 2025.

BibTeX

@misc{anon2025TheRol, title = {The Role of Qmax/eGFR Ratio in Assessing Symptom Severity and QoL in Men Over 40 With LUTS}, author = {Anonymous}, journal = {Marmara University}, year = {2025}, }